Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Halda Therapeutics is a research-stage drug discovery company.
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Vida Ventures has invested in 42 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vida Ventures's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 15 different industry categories.
Among tracked funding rounds, Praxis Precision Medicines received $575.0M in a Post-IPO Equity round. Vida Ventures's total known invested capital is $4.9B.
Vida Ventures's average investment size is $117.6M across its portfolio of 42 companies.
Recent Vida Ventures portfolio additions include Aktis Oncology, ReCode Therapeutics, Volastra Therapeutics, Dyne Therapeutics, Vigil Neuroscience. These companies were founded in 2020 or later.